JP2023519580A5 - - Google Patents
Info
- Publication number
- JP2023519580A5 JP2023519580A5 JP2022558119A JP2022558119A JP2023519580A5 JP 2023519580 A5 JP2023519580 A5 JP 2023519580A5 JP 2022558119 A JP2022558119 A JP 2022558119A JP 2022558119 A JP2022558119 A JP 2022558119A JP 2023519580 A5 JP2023519580 A5 JP 2023519580A5
- Authority
- JP
- Japan
- Prior art keywords
- combination
- composition according
- composition
- tnf
- anticancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063000431P | 2020-03-26 | 2020-03-26 | |
| US63/000,431 | 2020-03-26 | ||
| PCT/US2021/024523 WO2021195589A1 (en) | 2020-03-26 | 2021-03-26 | Method for treating therapy-resistant muc4+ cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023519580A JP2023519580A (ja) | 2023-05-11 |
| JP2023519580A5 true JP2023519580A5 (https=) | 2024-10-01 |
Family
ID=77890743
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022558119A Pending JP2023519580A (ja) | 2020-03-26 | 2021-03-26 | 治療抵抗性ｍｕｃ４＋癌を処置するための方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20230118642A1 (https=) |
| EP (1) | EP4262852A4 (https=) |
| JP (1) | JP2023519580A (https=) |
| CA (1) | CA3213069A1 (https=) |
| WO (1) | WO2021195589A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119264211A (zh) | 2018-08-27 | 2025-01-07 | 瑞泽恩制药公司 | 拉曼光谱在下游纯化中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5279235B2 (ja) * | 2007-11-05 | 2013-09-04 | 国立大学法人 岡山大学 | 抗癌剤耐性癌において抗癌剤増強作用を有する癌細胞死誘導剤 |
| US8362218B2 (en) * | 2009-04-17 | 2013-01-29 | New York University School Of Medicine | Peptides targeting TNF family receptors and antagonizing TNF action, compositions, methods and uses thereof |
| EP2963126B1 (en) * | 2013-03-01 | 2019-04-03 | Saitama Medical University | Method for evaluating side-effect onset risk in anticancer drug treatment, including detecting muc4 gene polymorphism |
| KR20180095037A (ko) * | 2015-12-18 | 2018-08-24 | 유니버시티 오브 피츠버그 - 오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 | 수용성 종양괴사인자의 억제에 의한 암의 예방 및 치료 |
| US20200147175A1 (en) * | 2018-11-10 | 2020-05-14 | Consejo Nacional De Investigaciones Científicas Y Técnicas | Method for treating anti-her2 therapy-resistant muc4+ her2+ cancer |
-
2021
- 2021-03-26 WO PCT/US2021/024523 patent/WO2021195589A1/en not_active Ceased
- 2021-03-26 EP EP21774064.6A patent/EP4262852A4/en active Pending
- 2021-03-26 US US17/914,462 patent/US20230118642A1/en active Pending
- 2021-03-26 CA CA3213069A patent/CA3213069A1/en active Pending
- 2021-03-26 JP JP2022558119A patent/JP2023519580A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006501147A5 (https=) | ||
| Liu et al. | Curcumin ameliorates dextran sulfate sodium-induced experimental colitis by blocking STAT3 signaling pathway | |
| CN101237880B (zh) | 通过vegf拮抗剂的皮下给药治疗疾病 | |
| JP2020059713A (ja) | 膠芽腫治療のための併用療法 | |
| JP2022031331A (ja) | 空間配置が変化した組換えインターフェロンを用いる腫瘍治療の方法 | |
| Qi et al. | Twenty years of Gendicine® rAd-p53 cancer gene therapy: The first-in-class human cancer gene therapy in the era of personalized oncology | |
| Thairu et al. | Angiogenesis as a therapeutic target in arthritis in 2011: learning the lessons of the colorectal cancer experience | |
| ES2736030T3 (es) | Politerapia para el tratamiento del cáncer de ovario | |
| Rascoe et al. | Molecular pathogenesis of malignant mesothelioma | |
| JP2017513908A5 (https=) | ||
| Kang et al. | Down-regulation of TGF-β expression sensitizes the resistance of hepatocellular carcinoma cells to sorafenib | |
| JP2018516244A5 (https=) | ||
| ES2425315A2 (es) | Composición farmacéutica y su uso para preparar un medicamento destinado al tratamiento sintomático de una enfermedad o afección respiratoria | |
| RU2011121616A (ru) | Лейколектины и их применение | |
| CN118019550A (zh) | 预防、缓解或治疗黏膜黏连的药物及其应用 | |
| Haller | Update of clinical trials with edrecolomab: a monoclonal antibody therapy for colorectal cancer | |
| JP2010532787A5 (https=) | ||
| JP2005502579A5 (https=) | ||
| JP2023519580A5 (https=) | ||
| JP2003509042A (ja) | 新規血管形成阻害剤 | |
| Denduluri et al. | Circulating biomarkers of bevacizumab activity in patients with breast cancer | |
| Chen et al. | The reparative effect of FOXM1 in pulmonary disease | |
| JP7291987B2 (ja) | チロシンキナーゼ阻害剤と併用してｅｇｆ／ｅｇｆｒ経路を抑制する方法および組成物 | |
| M Assifi et al. | Anti-angiogenic agents in pancreatic cancer: a review | |
| JP2007520564A5 (https=) |